146 related articles for article (PubMed ID: 33369476)
1. Inhibitory Effect of Orally Administered 5-Aminolevulinic Acid on Prostate Carcinogenesis in the FVB-Transgenic Adenocarcinoma of a Mouse Prostate (FVB-TRAMP) Model.
Onishi K; Miyake M; Tatsumi Y; Hori S; Nakai Y; Onishi S; Iemura Y; Owari T; Itami Y; Iida K; Anai S; Tanaka N; Shimada K; Fujimoto K
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3743-3749. PubMed ID: 33369476
[TBL] [Abstract][Full Text] [Related]
2. Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit.
Wang L; Bonorden MJ; Li GX; Lee HJ; Hu H; Zhang Y; Liao JD; Cleary MP; Lü J
Cancer Prev Res (Phila); 2009 May; 2(5):484-95. PubMed ID: 19401524
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.
Gupta S; Ahmad N; Marengo SR; MacLennan GT; Greenberg NM; Mukhtar H
Cancer Res; 2000 Sep; 60(18):5125-33. PubMed ID: 11016639
[TBL] [Abstract][Full Text] [Related]
4. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model.
Gupta S; Adhami VM; Subbarayan M; MacLennan GT; Lewin JS; Hafeli UO; Fu P; Mukhtar H
Cancer Res; 2004 May; 64(9):3334-43. PubMed ID: 15126378
[TBL] [Abstract][Full Text] [Related]
5. Gene expression signatures associated with suppression of TRAMP prostate carcinogenesis by a kavalactone-rich Kava fraction.
Tang SN; Zhang J; Jiang P; Datta P; Leitzman P; O'Sullivan MG; Jiang C; Xing C; Lü J
Mol Carcinog; 2016 Dec; 55(12):2291-2303. PubMed ID: 26840761
[TBL] [Abstract][Full Text] [Related]
6. Capsaicin reduces the metastatic burden in the transgenic adenocarcinoma of the mouse prostate model.
Venier NA; Yamamoto T; Sugar LM; Adomat H; Fleshner NE; Klotz LH; Venkateswaran V
Prostate; 2015 Sep; 75(12):1300-11. PubMed ID: 26047020
[TBL] [Abstract][Full Text] [Related]
7. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
Narayanan BA; Narayanan NK; Pittman B; Reddy BS
Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
[TBL] [Abstract][Full Text] [Related]
8. Chinese medicinal herb Scutellaria barbata modulates apoptosis and cell survival in murine and human prostate cancer cells and tumor development in TRAMP mice.
Wong BY; Nguyen DL; Lin T; Wong HH; Cavalcante A; Greenberg NM; Hausted RP; Zheng J
Eur J Cancer Prev; 2009 Aug; 18(4):331-41. PubMed ID: 19444125
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibitory and apoptotic effects of inositol hexaphosphate in transgenic adenocarcinoma of mouse prostate (TRAMP-C1) cells.
Sharma G; Singh RP; Agarwal R
Int J Oncol; 2003 Nov; 23(5):1413-8. PubMed ID: 14532984
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.
Wu GJ; Fu P; Chiang CF; Huss WJ; Greenberg NM; Wu MW
J Urol; 2005 May; 173(5):1778-83. PubMed ID: 15821586
[TBL] [Abstract][Full Text] [Related]
11. Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice.
Kim SJ; Amankwah E; Connors S; Park HY; Rincon M; Cornnell H; Chornokur G; Hashim AI; Choi J; Tsai YY; Engelman RW; Kumar N; Park JY
Cancer Prev Res (Phila); 2014 Apr; 7(4):435-44. PubMed ID: 24501325
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
13. 5-aminolevulinic acid mediated photodynamic therapy inhibits survival activity and promotes apoptosis of A375 and A431 cells.
Cai J; Zheng Q; Huang H; Li B
Photodiagnosis Photodyn Ther; 2018 Mar; 21():257-262. PubMed ID: 29309850
[TBL] [Abstract][Full Text] [Related]
14. Dual benefit of supplementary oral 5-aminolevulinic acid to pelvic radiotherapy in a syngenic prostate cancer model.
Miyake M; Tanaka N; Hori S; Ohnishi S; Takahashi H; Fujii T; Owari T; Ohnishi K; Iida K; Morizawa Y; Gotoh D; Itami Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Fujimoto K
Prostate; 2019 Mar; 79(4):340-351. PubMed ID: 30450646
[TBL] [Abstract][Full Text] [Related]
15. 3,3'-Diindolylmethane inhibits prostate cancer development in the transgenic adenocarcinoma mouse prostate model.
Cho HJ; Park SY; Kim EJ; Kim JK; Park JH
Mol Carcinog; 2011 Feb; 50(2):100-12. PubMed ID: 21229607
[TBL] [Abstract][Full Text] [Related]
16. Chemopreventive effect of Korean Angelica root extract on TRAMP carcinogenesis and integrative "omic" profiling of affected neuroendocrine carcinomas.
Zhang J; Wang L; Zhang Y; Li L; Tang S; Xing C; Kim SH; Jiang C; Lü J
Mol Carcinog; 2015 Dec; 54(12):1567-83. PubMed ID: 25307620
[TBL] [Abstract][Full Text] [Related]
17. Low-lycopene containing tomato powder diet does not protect against prostate cancer in TRAMP mice.
Conlon LE; Wallig MA; Erdman JW
Nutr Res; 2015 Oct; 35(10):882-890. PubMed ID: 26255194
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of withaferin A inhibits carcinogenesis of prostate in TRAMP model.
Suman S; Das TP; Moselhy J; Pal D; Kolluru V; Alatassi H; Ankem MK; Damodaran C
Oncotarget; 2016 Aug; 7(33):53751-53761. PubMed ID: 27447565
[TBL] [Abstract][Full Text] [Related]
19. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
Raina K; Blouin MJ; Singh RP; Majeed N; Deep G; Varghese L; Glodé LM; Greenberg NM; Hwang D; Cohen P; Pollak MN; Agarwal R
Cancer Res; 2007 Nov; 67(22):11083-91. PubMed ID: 18006855
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.
Narayanan BA; Narayanan NK; Pttman B; Reddy BS
Prostate; 2006 Feb; 66(3):257-65. PubMed ID: 16175586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]